| Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority … AM Brunt, JS Haviland, DA Wheatley, MA Sydenham, A Alhasso, ... The Lancet 395 (10237), 1613-1626, 2020 | 913 | 2020 |
| Using cost-effectiveness analysis to address health equity concerns R Cookson, AJ Mirelman, S Griffin, M Asaria, B Dawkins, OF Norheim, ... Value in Health 20 (2), 206-212, 2017 | 322 | 2017 |
| Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis C McDaid, S Griffin, H Weatherly, K Duree, M Van der Burgt, S Van Hout, ... Health Technology Assessment 13 (4), 1-146, 2009 | 272 | 2009 |
| Statistical analysis AL Clark, M Johnson, C Fairhurst, D Torgerson, S Cockayne, S Rodgers, ... Does home oxygen therapy (HOT) in addition to standard care reduce disease …, 2015 | 249 | 2015 |
| Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial A McMillan, DJ Bratton, R Faria, M Laskawiec-Szkonter, S Griffin, ... The Lancet Respiratory Medicine 2 (10), 804-812, 2014 | 239 | 2014 |
| A systematic review of continuous positive airway pressure for obstructive sleep apnoea–hypopnoea syndrome C McDaid, KH Durée, SC Griffin, HLA Weatherly, JR Stradling, ... Sleep medicine reviews 13 (6), 427-436, 2009 | 238 | 2009 |
| Distributional cost-effectiveness analysis: a tutorial M Asaria, S Griffin, R Cookson Medical Decision Making 36 (1), 8-19, 2016 | 231 | 2016 |
| A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit … S King, S Griffin, Z Hodges, H Weatherly, C Asseburg, G Richardson, ... Health Technology Assessment (Winchester, England) 10 (23), iii-146, 2006 | 223 | 2006 |
| Distributional cost‐effectiveness analysis of health care programmes–a methodological case study of the UK bowel cancer screening programme M Asaria, S Griffin, R Cookson, S Whyte, P Tappenden Health economics 24 (6), 742-754, 2015 | 144 | 2015 |
| Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development K Claxton, S Palmer, L Longworth, L Bojke, S Griffin, C McKenna, ... NIHR Health Technology Assessment Programme, 2012 | 137 | 2012 |
| Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study SC Griffin, JA Barber, A Manca, MJ Sculpher, SG Thompson, MJ Buxton, ... Bmj 334 (7594), 624, 2007 | 133 | 2007 |
| Dangerous omissions: the consequences of ignoring decision uncertainty SC Griffin, KP Claxton, SJ Palmer, MJ Sculpher Health economics 20 (2), 212-224, 2011 | 132 | 2011 |
| The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation D Farrar, M Simmonds, S Griffin, A Duarte, DA Lawlor, M Sculpher, ... Health technology assessment 20 (86), 1-348, 2016 | 129 | 2016 |
| Distributional cost-effectiveness analysis: quantifying health equity impacts and trade-offs R Cookson, S Griffin, OF Norheim, AJ Culyer Oxford University Press, 2020 | 119 | 2020 |
| Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose A McIntosh, A Hutchinson, PD Home, F Brown, A Bruce, A Damerell, ... Sheffield: ScHARR, University of Sheffield, 2001 | 114 | 2001 |
| Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision makers S Walker, S Griffin, M Asaria, A Tsuchiya, M Sculpher Applied health economics and health policy 17, 577-590, 2019 | 111 | 2019 |
| Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and … L Jones, S Griffin, S Palmer, C Main, V Orton, M Sculpher, C Sudlow, ... Health Technology Assessment (Winchester, England) 8 (38), iii-196, 2004 | 104 | 2004 |
| The social distribution of health: estimating quality-adjusted life expectancy in England J Love-Koh, M Asaria, R Cookson, S Griffin Value in health 18 (5), 655-662, 2015 | 95 | 2015 |
| Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic … C Main, S Palmer, S Griffin, L Jones, V Orton, M Sculpher, R Henderson, ... Health technology assessment (Winchester, England) 8 (40), iii-141, 2004 | 93 | 2004 |
| Probabilistic analysis and computationally expensive models: necessary and required? S Griffin, K Claxton, N Hawkins, M Sculpher Value in Health 9 (4), 244-252, 2006 | 87 | 2006 |
